… However it is not known whether blocking GSK3β signaling is neuroprotective and ameliorates
… We found that the neuroprotective effects of blocking GSK3β in vivo was associated with …

… caused synergistic neuroprotection … neuroprotective effects of lithium and HDAC inhibitors
and suggest that GSK-3 inhibition is a likely molecular target for the synergistic neuroprotection…

The present study has been designed to explore the possible interaction between
hemeoxygenase-1 (HO-1) and glycogen synthase kinase-3β (GSK-3β) pathway in 3-nitropropionic …

… of lithium (eg, [37–41]), and some reported evidence for neuroprotection by VPA [42,43], and
LTG [44–46], by identifying a specific mechanism contributing to their neuroprotective effects…

… disorder, has shown neuroprotective effects through glycogen synthase kinase-3β … glycogen
synthase kinase-3β activity. Our results showed lithium chloride inhibited glycogen synthase …

… Metformin has been suggested to have protective effects on … effects of metformin and the
inhibition of glycogen synthase … whether the effects of metformin on neuroprotection and …

… in the ATP binding site of glycogen synthase kinase 3β and mitogen activated protein kinase…
might produce neuroprotective effects via concurrent inhibition of glycogen synthase kinase …

… of SKF83959 and its potential mechanism for the effect in cultured rat cortical cells. … glycogen
synthase kinase-3β (GSK-3β) which was associated with the drug’s neuroprotective effect, …

… The neuroprotective actions of lithium have begun to be tested for their more specific …
Lithium showed neuroprotective effects against neurotoxicity induced by MPTP (N-methyl-4-phenyl-…

… , the IL-4-induced neuroprotective effect in IR was blocked by the Akt inhibitor LY294002.
Thus, these results demonstrate that IL-4 pretreatment could exert neuroprotective effects by …